The Pt(<i>S</i>-pr-thiosal)2 and BCL1 Leukemia Lymphoma: Antitumor Activity In Vitro and In Vivo.

Int J Mol Sci · 2022 · PMC9332548 · PMID 35897737

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Treatment with the Pt( S -pr-thiosal)2 complex also reduced the percentage of BCL1 cells expressing cyclin D3, although this difference did not reach statistical significance ( Figure 4 d).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.